Logo image
The New Zealand neuromuscular disease registry
Journal article   Peer reviewed

The New Zealand neuromuscular disease registry

M. Rodrigues, G. Hammond-Tooke, A. Kidd, D. Love, R. Patel, H. Dawkins, M. Bellgard and R. Roxburgh
Journal of Clinical Neuroscience, Vol.19(12), pp.1749-1750
2012
url
Link to Published Version *Subscription may be requiredView

Abstract

The development of effective treatments for neuromuscular diseases is a significant challenge due to difficulties in identifying adequate numbers of patients for clinical trials. Low patient numbers in these rare diseases also has an effect when establishing sound clinical practices based on experience gained from patients with similar diagnosis. The Muscular Dystrophy Association of New Zealand (MDA), working in consort with interested clinicians has established the New Zealand Neuromuscular Disease (NZ NMD) Registry in order to help address these problems. The NZ NMD Registry is exceptional in that it comprises one registry for all neuromuscular conditions and will significantly benefit both patients with neuromuscular disease and their clinicians.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Industry collaboration
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.79 Molecular & Cell Biology - Physiology
1.79.1811 Myotonic Dystrophy Mechanisms
Web Of Science research areas
Clinical Neurology
Neurosciences
ESI research areas
Neuroscience & Behavior
Logo image